Cellular response to etoposide treatment

Cancer Letters

Volumn 252, Issue 1, 2007, Pages 9-18

  Montecucco, Alessandra ^a   Biamonti, Giuseppe ^a  

^a CNR   (Italy)

Author keywords

Alternative splicing; Anticancer drugs; Apoptosis; ATM; ATR; Cell cycle; Chromatin; DNA damage checkpoint; DNA repair; DNA replication; DNA topoisomerase; Double stranded breaks; Etoposide; PCNA; Replication factories; Topoisomerase poisons

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE;

CELL CYCLE; CELL METABOLISM; CYTOTOXICITY; DNA DAMAGE; DNA REPLICATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 34248356003     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.11.005     Document Type: Review

References (60)

1. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70 (2001) 369-413
2. Li T.K., and Liu L.F. Tumor cell death induced by topoisomerase-targeting drugs. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 53-77
3. Hande K.R. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 34 (1998) 1514-1521
4. Burden D.A., Kingma P.S., Froelich-Ammon S.J., et al. Topoisomerase II. Etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J. Biol. Chem. 271 (1996) 29238-29244
5. Bromberg K.D., Burgin A.B., and Osheroff N. A two-drug model for etoposide action against human topoisomerase IIalpha. J. Biol. Chem. 278 (2003) 7406-7412
6. Vilain N., Tsai-Pflugfelder M., Benoit A., Gasser S.M., and Leroy D. Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalpha. Nucleic Acids Res. 31 (2003) 5714-5722
7. Connelly J.C., and Leach D.R. Repair of DNA covalently linked to protein. Mol. Cell 13 (2004) 307-316
8. Neale M.J., Pan J., and Keeney S. Endonucleolytic processing of covalent protein-linked DNA double-strand breaks. Nature 436 (2005) 1053-1057
9. Stracker T.H., Carson C.T., and Weitzman M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418 (2002) 348-352
10. Mao Y., Desai S.D., Ting C.Y., Hwang J., and Liu L.F. 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. J. Biol. Chem. 276 (2001) 40652-40658
11. Caldecott K., Banks G., and Jeggo P. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II. Cancer Res. 50 (1990) 5778-5783
12. Rossi R., Lidonnici M.R., Soza S., Biamonti G., and Montecucco A. The dispersal of replication proteins after Etoposide treatment requires the cooperation of Nbs1 with the ataxia telangiectasia Rad3-related/Chk1 pathway. Cancer Res. 66 (2006) 1675-1683
13. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998) 5858-5868
14. Elledge S.J. Cell cycle checkpoints: preventing an identity crisis. Science 274 (1996) 1664-1672
15. Bartek J., Lukas C., and Lukas J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 5 (2004) 792-804
16. Shechter D., Costanzo V., and Gautier J. Regulation of DNA replication by ATR: signaling in response to DNA intermediates. DNA Repair(Amst) 3 (2004) 901-908
17. Agner J., Falck J., Lukas J., and Bartek J. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway. Exp. Cell Res. 302 (2005) 162-169
18. Hansen L.T., Lundin C., Helleday T., et al. DNA repair rate and etoposide (VP16) resistance of tumor cell subpopulations derived from a single human small cell lung cancer. Lung Cancer 40 (2003) 157-164
19. Caporossi D., Porfirio B., Nicoletti B., et al. Hypersensitivity of lymphoblastoid lines derived from ataxia telangiectasia patients to the induction of chromosomal aberrations by etoposide (VP-16). Mutat. Res. 290 (1993) 265-272
20. Pandita T.K., and Hittelman W.N. Initial chromosome damage but not DNA damage is greater in ataxia telangiectasia cells. Radiat. Res. 130 (1992) 94-103
21. Maser R.S., Monsen K.J., Nelms B.E., and Petrini J.H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell Biol. 17 (1997) 6087-6096
22. Robison J.G., Lu L., Dixon K., and Bissler J.J. DNA lesion-specific co-localization of the Mre11/Rad50/Nbs1 (MRN) complex and replication protein A (RPA) to repair foci. J. Biol. Chem. 280 (2005) 12927-12934
23. Costanzo V., Shechter D., Lupardus P.J., Cimprich K.A., Gottesman M., and Gautier J. An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol. Cell 11 (2003) 203-213
24. Loegering D., Arlander S.J., Hackbarth J., et al. Rad9 protects cells from topoisomerase poison-induced cell death. J. Biol. Chem. 279 (2004) 18641-18647
25. Montecucco A., Rossi R., Ferrari G., Scovassi A.I., Prosperi E., and Biamonti G. Etoposide induces the dispersal of DNA ligase I from replication factories. Mol. Biol. Cell 12 (2001) 2109-2118
26. Levine C., Hiasa H., and Marians K.J. DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim. Biophys. Acta 1400 (1998) 29-43
27. McClendon A.K., Rodriguez A.C., and Osheroff N. Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks. J. Biol. Chem. 280 (2005) 39337-39345
28. Hong G., and Kreuzer K.N. Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes. Proc. Natl. Acad. Sci. USA 100 (2003) 5046-5051
29. Holm C., Covey J.M., Kerrigan D., and Pommier Y. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res. 49 (1989) 6365-6368
30. Wang J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 3 (2002) 430-440
31. Cuvier O., and Hirano T. A role of topoisomerase II in linking DNA replication to chromosome condensation. J. Cell Biol. 160 (2003) 645-655
32. Downes C.S., Clarke D.J., Mullinger A.M., Gimenez-Abian J.F., Creighton A.M., and Johnson R.T. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372 (1994) 467-470
33. Lucas I., Germe T., Chevrier-Miller M., and Hyrien O. Topoisomerase II can unlink replicating DNA by precatenane removal. EMBO J. 20 (2001) 6509-6519
34. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
35. Bell S.P., and Dutta A. DNA replication in eukaryotic cells. Annu. Rev. Biochem. 71 (2002) 333-374
36. Frouin I., Montecucco A., Spadari S., and Maga G. DNA replication: a complex matter. EMBO Rep. 4 (2003) 666-670
37. O'Keefe R.T., Henderson S.C., and Spector D.L. Dynamic organization of DNA replication in mammalian cell nuclei: spatially and temporally defined replication of chromosome-specific alpha-satellite DNA sequences. J. Cell Biol. 116 (1992) 1095-1110
38. Dimitrova D.S., and Gilbert D.M. Temporally coordinated assembly and disassembly of replication factories in the absence of DNA synthesis. Nat. Cell Biol. 2 (2000) 686-694
39. Lagarkova M.A., Svetlova E., Giacca M., Falaschi A., and Razin S.V. DNA loop anchorage region colocalizes with the replication origin located downstream to the human gene encoding lamin B2. J. Cell Biochem. 69 (1998) 13-18
40. Paixao S., Colaluca I.N., Cubells M., et al. Modular structure of the human lamin B2 replicator. Mol. Cell Biol. 24 (2004) 2958-2967
41. Dierov J., Dierova R., and Carroll M. BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint. Cancer Cell 5 (2004) 275-285
42. Hirano T. At the heart of the chromosome: SMC proteins in action. Nat. Rev. Mol. Cell Biol. 7 (2006) 311-322
43. Sjogren C., and Nasmyth K. Sister chromatid cohesion is required for postreplicative double-strand break repair in Saccharomyces cerevisiae. Curr. Biol. 11 (2001) 991-995
44. Kim S.T., Xu B., and Kastan M.B. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev. 16 (2002) 560-570
45. Yazdi P.T., Wang Y., Zhao S., Patel N., Lee E.Y., and Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16 (2002) 571-582
46. Musio A., Montagna C., Mariani T., et al. SMC1 involvement in fragile site expression. Hum. Mol. Genet. 14 (2005) 525-533
47. Tsai S.C., Valkov N., Yang W.M., Gump J., Sullivan D., and Seto E. Histone deacetylase interacts directly with DNA topoisomerase II. Nat. Genet. 26 (2000) 349-353
48. Johnson C.A., Padget K., Austin C.A., and Turner B.M. Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis. J. Biol. Chem. 276 (2001) 4539-4542
49. Jiao W., Lin H.M., Timmons J., et al. E2F-dependent repression of topoisomerase II regulates heterochromatin formation and apoptosis in cells with melanoma-prone mutation. Cancer Res. 65 (2005) 4067-4077
50. Riedl S.J., and Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5 (2004) 897-907
51. Kaufmann S.H., and Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256 (2000) 42-49
52. Wang P., Song J.H., Song D.K., Zhang J., and Hao C. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis. Cell Signal. 18 (2006) 1528-1535
53. Kaufmann S.H. Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim. Biophys. Acta 1400 (1998) 195-211
54. Rossi R., Montecucco A., Donzelli M., Denegri M., Biamonti G., and Scovassi A. DNA ligase I is dephosphorylated during the execution step of etoposide-induced apoptosis. Cell Death Differ. 9 (2002) 89-90
55. Soldani C., Bottone M.G., Pellicciari C., and Scovassi A.I. Two-color fluorescence detection of poly (ADP-ribose) polymerase-1 (PARP-1) cleavage and DNA strand breaks in etoposide-induced apoptotic cells. Eur. J. Histochem. 45 (2001) 389-392
56. Negri C., Donzelli M., Bernardi R., Rossi L., Burkle A., and Scovassi A.I. Multiparametric staining to identify apoptotic human cells. Exp. Cell Res. 234 (1997) 174-177
57. Morana S.J., Wolf C.M., Li J., Reynolds J.E., Brown M.K., and Eastman A. The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis. J. Biol. Chem. 271 (1996) 18263-18271
58. Stacey D.W., Hitomi M., and Chen G. Influence of cell cycle and oncogene activity upon topoisomerase IIalpha expression and drug toxicity. Mol. Cell Biol. 20 (2000) 9127-9137
59. Wotawa A., Solier S., Logette E., Solary E., and Corcos L. Differential influence of etoposide on two caspase-2 mRNA isoforms in leukemic cells. Cancer Lett. 185 (2002) 181-189
60. Solier S., Lansiaux A., Logette E., et al. Topoisomerase I and II inhibitors control caspase-2 pre-messenger RNA splicing in human cells. Mol. Cancer Res. 2 (2004) 53-61